A randomized controlled trial by a parallel group design in multi-institutions to evaluate the effectiveness of oral adjuvant chemotherapy using Leucovorin and Tegaful/Uracil to prevent recurrence after resection of liver metastasis from colorectal carcinoma.

Trial Profile

A randomized controlled trial by a parallel group design in multi-institutions to evaluate the effectiveness of oral adjuvant chemotherapy using Leucovorin and Tegaful/Uracil to prevent recurrence after resection of liver metastasis from colorectal carcinoma.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Mar 2017

At a glance

  • Drugs Folinic acid (Primary) ; Tegafur/uracil (Primary)
  • Indications Cancer metastases; Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Mar 2017 Status changed from active, no longer recruiting to completed, according to the results presented at the 2017 Gastrointestinal Cancers Symposium.
    • 21 Jan 2017 Results evaluating long-term overall survival presented at the 2017 Gastrointestinal Cancers Symposium.
    • 28 Sep 2012 The 180 patients were enrolled between January 2004 and December 2010, according to the abstract presented at ESMO.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top